7‐year follow‐up after stereotactic ablative radiotherapy for patients with stage I non–small cell lung cancer: Results of a phase 2 clinical trial
B Sun, ED Brooks, RU Komaki, Z Liao, MD Jeter… - Cancer, 2017 - Wiley Online Library
BACKGROUND The authors evaluated the efficacy, patterns of failure, and toxicity of
stereotactic ablative radiotherapy (SABR) for patients with medically inoperable, clinical …
stereotactic ablative radiotherapy (SABR) for patients with medically inoperable, clinical …
Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small cell lung cancer
FJ Lagerwaard, NE Verstegen, CJA Haasbeek… - International Journal of …, 2012 - Elsevier
BACKGROUND: Approximately two-thirds of patients with early-stage non-small-cell lung
cancer (NSCLC) in The Netherlands currently undergo surgical resection. As an increasing …
cancer (NSCLC) in The Netherlands currently undergo surgical resection. As an increasing …
Stereotactic ablative radiotherapy for stage I histologically proven non-small cell lung cancer: an Italian multicenter observational study
U Ricardi, G Frezza, AR Filippi, S Badellino, M Levis… - Lung cancer, 2014 - Elsevier
Objectives Aim of this retrospective multicenter observational study was to provide data on
outcomes and prognostic factors in patients affected with stage I histologically confirmed …
outcomes and prognostic factors in patients affected with stage I histologically confirmed …
[HTML][HTML] Clinical outcome and predictors of survival and pneumonitis after stereotactic ablative radiotherapy for stage I non-small cell lung cancer
JY Chang, H Liu, P Balter, R Komaki, Z Liao, J Welsh… - Radiation …, 2012 - Springer
Background Stereotactic ablative radiotherapy (SABR) can achieve excellent local control
rates in early-stage non-small cell lung cancer (NSCLC) and has emerged as a standard …
rates in early-stage non-small cell lung cancer (NSCLC) and has emerged as a standard …
Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer: a retrospective analysis
S Senthi, FJ Lagerwaard, CJA Haasbeek… - The lancet …, 2012 - thelancet.com
Background Stereotactic ablative radiotherapy (SABR) is increasingly used in the treatment
of medically inoperable early stage non-small-cell lung cancer (NSCLC). Because patterns …
of medically inoperable early stage non-small-cell lung cancer (NSCLC). Because patterns …
Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified …
JY Chang, RJ Mehran, L Feng, V Verma, Z Liao… - The Lancet …, 2021 - thelancet.com
Background A previous pooled analysis of the STARS and ROSEL trials showed higher
survival after stereotactic ablative radiotherapy (SABR) than with surgery for operable early …
survival after stereotactic ablative radiotherapy (SABR) than with surgery for operable early …
[HTML][HTML] Stereotactic radiotherapy (SABR) for the treatment of primary non-small cell lung cancer; systematic review and comparison with a surgical cohort
F Soldà, M Lodge, S Ashley, A Whitington… - Radiotherapy and …, 2013 - Elsevier
Background and purpose To assess the efficacy of stereotactic ablative radiotherapy (SABR)
for the treatment of non-small cell lung cancer (NSCLC) through a systematic review of all …
for the treatment of non-small cell lung cancer (NSCLC) through a systematic review of all …
Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised …
Background Stereotactic ablative body radiotherapy (SABR) is widely used to treat
inoperable stage 1 non-small-cell lung cancer (NSCLC), despite the absence of prospective …
inoperable stage 1 non-small-cell lung cancer (NSCLC), despite the absence of prospective …
[HTML][HTML] Use of stereotactic ablative radiotherapy (SABR) in non–small cell lung cancer measuring more than 5 cm
H Tekatli, S van't Hof, EJ Nossent, M Dahele… - Journal of Thoracic …, 2017 - Elsevier
Introduction Stereotactic ablative radiotherapy (SABR) is currently not the guideline-
recommended treatment for lung tumors measuring more than 5 cm. However …
recommended treatment for lung tumors measuring more than 5 cm. However …
Stereotactic ablative radiotherapy (SABR) in early stage non-small cell lung cancer: comparing survival outcomes in adenocarcinoma and squamous cell carcinoma
Purpose Recent retrospective studies have demonstrated mixed results regarding the
histologic association of squamous cell carcinoma (SCC) with reduced overall survival in …
histologic association of squamous cell carcinoma (SCC) with reduced overall survival in …